IPO Stock Of The Week Pacs Group (PACS) plunged Friday, breaking down below a key level. Pacs stock was in Investor’s Business Daily’s IPO Leaders screen and had been nearing a buy point ahead of the health care holding company’s fourth-quarter earnings report.
Founded in 2013, Pacs Group operates more than 300 skilled nursing facilities and assisted living facilities across 17 states.
↑
X
This video file cannot be played.(Error Code: 102630)
Beyond The Breakout: How To Play Broadcom, Viking And Embraer After Earnings
See All Videos
NOW PLAYING
Beyond The Breakout: How To Play Broadcom, Viking And Embraer After Earnings
Pacs earned 42 cents per share, according to MarketSurge data, missing Wall Street’s consensus estimate of 45 cents. Sales rose 12% to $1.35 billion in the fourth quarter.
The company also provided a full-year outlook for 2026. It expects revenue in the range of $5.65 billion to $5.75 billion and adjusted EBITDA of $555 million to $575 million. Analysts polled by FactSet projected, on average, revenue of $5.71 billion and adjusted EBITDA of $548.2 million.
In November, Pacs said it caught up with filing obligations with the Securities and Exchange Commission and posted a strong full-year sales outlook, assuaging investor worries. In response, shares leapt to their highest level since November 2024.
IBD Newsletters
Get exclusive IBD analysis and actionable news daily.
SIGN UP NOW!
IBD Newsletters
Get exclusive IBD analysis and actionable news daily.
*
How To Invest
*
Market Prep
*
Tech Report
Please enter a valid email address
Please select a newsletter
GO
Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use
x
Thank You!
You will now receive IBD Newsletters
ALL DONE!
Something Went Wrong!
Please contact customer service
CLOSE
Pacs Stock Breaks Key Level
On Friday, Pacs stock plunged nearly 13% in afternoon trade, breaking below its 50-day moving average. That’s a key sell signal.
When a stock that has been trending higher for months falls under its 50-day line, that suggests institutional selling is occurring, especially if the break happens in heavy volume. Volume was tracking nearly 300% above average on Friday.
The stock had been forming a cup with handle with a 42.09 buy point, according to its IBD MarketSurge chart. But that buy point is no longer valid, and the stock will need to form another base before a new buying opportunity emerges.
Friday’s action underscores the danger of jumping into a stock ahead of a proper breakout, especially ahead of a quarterly earnings report.
In the IBD Stock Checkup, Pacs stock shows a near-best 98 IBD Composite Rating, which illustrated the name’s robust all-around strength. But that rating will almost surely deteriorate following Friday’s bearish action.
**As Wall Street Wavers, What’s An Investor To Do? Start Here
**
Be sure to follow Scott Lehtonen on X at @IBD_SLehtonen for more on the Dow Jones Industrial Average and the stock market today.
YOU MAY ALSO LIKE:
Check Out IBD’s New Exposure Levels To Help You Stay In Step With The Market Trend
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
Spot Buy Points And Sell Signals With MarketSurge Pattern Recognition
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
IPO Stock Of The Week: Pacs Group Plunges Through Key Level After Earnings Weakness
IPO Stock Of The Week Pacs Group (PACS) plunged Friday, breaking down below a key level. Pacs stock was in Investor’s Business Daily’s IPO Leaders screen and had been nearing a buy point ahead of the health care holding company’s fourth-quarter earnings report.
Founded in 2013, Pacs Group operates more than 300 skilled nursing facilities and assisted living facilities across 17 states.
This video file cannot be played.(Error Code: 102630)
Pacs earned 42 cents per share, according to MarketSurge data, missing Wall Street’s consensus estimate of 45 cents. Sales rose 12% to $1.35 billion in the fourth quarter.
The company also provided a full-year outlook for 2026. It expects revenue in the range of $5.65 billion to $5.75 billion and adjusted EBITDA of $555 million to $575 million. Analysts polled by FactSet projected, on average, revenue of $5.71 billion and adjusted EBITDA of $548.2 million.
In November, Pacs said it caught up with filing obligations with the Securities and Exchange Commission and posted a strong full-year sales outlook, assuaging investor worries. In response, shares leapt to their highest level since November 2024.
IBD Newsletters
Get exclusive IBD analysis and actionable news daily.
IBD Newsletters
Get exclusive IBD analysis and actionable news daily.
Please enter a valid email address
Please select a newsletter
Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use
Thank You!
You will now receive IBD Newsletters
Something Went Wrong!
Please contact customer service
Pacs Stock Breaks Key Level
On Friday, Pacs stock plunged nearly 13% in afternoon trade, breaking below its 50-day moving average. That’s a key sell signal.
When a stock that has been trending higher for months falls under its 50-day line, that suggests institutional selling is occurring, especially if the break happens in heavy volume. Volume was tracking nearly 300% above average on Friday.
The stock had been forming a cup with handle with a 42.09 buy point, according to its IBD MarketSurge chart. But that buy point is no longer valid, and the stock will need to form another base before a new buying opportunity emerges.
Friday’s action underscores the danger of jumping into a stock ahead of a proper breakout, especially ahead of a quarterly earnings report.
In the IBD Stock Checkup, Pacs stock shows a near-best 98 IBD Composite Rating, which illustrated the name’s robust all-around strength. But that rating will almost surely deteriorate following Friday’s bearish action.
**As Wall Street Wavers, What’s An Investor To Do? Start Here
**
Be sure to follow Scott Lehtonen on X at @IBD_SLehtonen for more on the Dow Jones Industrial Average and the stock market today.
YOU MAY ALSO LIKE:
Check Out IBD’s New Exposure Levels To Help You Stay In Step With The Market Trend
Top Growth Stocks To Buy And Watch
Learn How To Time The Market With IBD’s ETF Market Strategy
Find The Best Long-Term Investments With IBD Long-Term Leaders
Spot Buy Points And Sell Signals With MarketSurge Pattern Recognition